試す 金 - 無料
Transforming Diagnostics and Personalized Medicine Amidst Challenges
The Business Guardian
|December 29, 2024
Genomic testing, an advanced diagnostic tool, delves deep into the analysis of DNA, RNA, and proteomics to uncover genetic mutations, assess disease risks, and provide critical insights for medical decisions.
The field has seen transformative progress with the advent of technologies like next-generation sequencing, enabling the early detection of diseases, particularly cancers.
This cutting-edge approach has significantly enhanced diagnostic precision, making it a cornerstone in personalized medicine. However, challenges persist. Restricted insurance coverage, high costs, and the complexity of interpreting vast genomic data continue to hinder its widespread adoption.
These obstacles underscore the need for robust frameworks to ensure accessibility and affordability.
To shed light on this evolving field and its implications for healthcare, we turn to Dr. Kirti Chadha, Chief Scientific and Innovation Officer at Metropolis Healthcare Limited.
Q: What is genomic testing, and how does it differ from traditional diagnostic tests?
A: In 2003, the Human Genome Project that mapped an understanding of all human genes was completed and changed the entire testing scope impacting every clinical segment. Although genetic testing started way back in 1950 when Down (trisomy 21) and other syndromes were diagnosed by cytogenetic methods & evolved further in 1990s when the novel technique of PCR accelerated molecular genetic testing by enabling targeted testing for known pathogenic variants, it accelerated only when Next Generation Sequencing & other newer technologies added to the understanding of the human genome and its impact on disease.
Testing has now evolved from comprehensive gene panels to exome and genome sequencing as routine tests, thereby revolutionizing the diagnosis of rare genetic diseases among others.
As compared to traditional lab tests, genomic tests that study DNA, RNA, proteomics can identify mutations in our genes indicating if we have or not a genetic condition while also identifying our risk for developing a certain condition or passing on a genetic disorder to the next generation.
このストーリーは、The Business Guardian の December 29, 2024 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、10,000 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
The Business Guardian からのその他のストーリー
The Business Guardian
COURT NOTES CENTRE'S LABOUR CODE PLEDGE
Assuring itself that no legal vacuum will be allowed during the shift to the new labour law framework, the Delhi High Court has recently said it trusts the Central government to ensure a seamless transition from the old regime to the Industrial Relations Code, 2020.
1 mins
December 14, 2025
The Business Guardian
DoP partners BSE to expand Mutual Fund access across India
The Department of Posts (DoP), Ministry of Communications and the stock exchange BSE signed a Memorandum of Understanding (MoU) in line with the Budget 2025-26 announcement, which emphasised leveraging India Post's vast postal network as a catalyst for economic activity in rural and semi-urban regions.
1 mins
December 14, 2025
The Business Guardian
INDIA RETAIL INFLATION TO AVERAGE 2.5% IN 2025-26 FISCAL
As the base effect on food fades, headline Consumer Price Index or retail inflation is likely to edge up slightly to average at 2.5 per cent this financial year 2025-26, Crisil has asserted.
1 mins
December 14, 2025
The Business Guardian
Court hands double life term for step-daughter rape
The District and Sessions Court of Indore has sentenced an accused of raping his stepdaughter to double life imprisonment under relevant sections of the Protection of Children from Sexual Offences (POCSO) Act.
1 mins
December 14, 2025
The Business Guardian
Nvidia eyes higher H200 chip output
Nvidia has told Chinese clients it is evaluating adding production capacity for its powerful H200 AI chips after orders exceeded its current output level, according to two sources briefed on the matter.
1 min
December 14, 2025
The Business Guardian
TARIFFS HAVE COST EACH U.S. HOUSEHOLD $1,200
Sweeping taxes on imports have cost the average American household nearly $1,200 since Donald Trump returned to the White House this year, according to calculations by Democrats on Congress’ Joint Economic Committee.
2 mins
December 14, 2025
The Business Guardian
CTA APPARELS HAILS INDIA-EU FTA PROGRESS
Indian garment manufacturer CTA Apparels has applauded the Government of India's encouraging progress on the India-EU Free Trade Agreement (FTA), with the blueprint now in advanced stages.
1 mins
December 14, 2025
The Business Guardian
GST reforms may reduce retail inflation by 35 basis points
The decline in Consumer Price Index (CPI) or retail inflation due to massive GST rate rationalisation has been around 25 bps so far in the September-November 2025 period, according to estimates put forth by SBI Research.
1 min
December 14, 2025
The Business Guardian
Shiprocket files updated IPO papers, eyes Rs 2,342 cr issue
Temasek-backed e-commerce enablement platform Shiprocket has filed updated draft papers with markets regulator Sebi to raise a little over Rs 2,342 crore through its initial public offering (IPO).
1 mins
December 14, 2025
The Business Guardian
Sense of relief: Zubeen's uncle on SIT charge-sheet
Late singer Zubeen Garg’s uncle Manoj Borthakur felt “a sense of relief” after the Special Investigation Team (SIT) of Assam Police filed a 12,000-page chargesheet on Friday regarding the investigation of the singer's demise.
1 mins
December 14, 2025
Listen
Translate
Change font size
